Center for Urological Credit Treatment and Spezieller-versorgung hat Arbeit aufgenommen

The St. Antonius Hospital Gronau and more lower regions in the region have been treating patients with complex urological tumors collectively in Rahmen “Ambulanter Spezialfachärztlicher Versorgung” (ASV) since July. Together with our cooperation partners, the Clinic for Urology offers an optimized outpatient treatment and, despite the special care provided by more complex urological tumor cancers, it is specifically tailored to the disease in a Pressetext. Jetzt und der official Auftaktveranstaltung statt.

The ASV is no longer dependent on the fachübergreifende and wohnortnahe-versorgung by hereditary specialists. ASV patients have undergone a number of specific treatment and management methods, involving special nuclear medicine treatment, such as the PSMA-PET/CT. The medical therapy was expanded to include the medical indication in the St. Antonius Hospital Gronau. Other components of the ganzheitlichen constructions are a supporting role in social services, psychology and ernährungsberatung.

Extensive expertise

The ASV Core Team under the leadership of Dr. Miriam Hegemann, Oberärztin in the Clinic for Urology, Urological Oncology and Robotic Assisted Surgery, has brought his sister together with the Fachdisziplines Urology, Inner Medizin, Hämatology and Onkology for Strahlentherapie. More information about further information – Darunter Radiology, Nuclear Medicine and Gynäkology – could be found here. There are specialists in the clinic for medical treatments and therapies at the Institute for Teams.

Jedes ASV-Mitglied must have the qualification and knowledge in the care of patients with urological tumors, heißt es in der Presseilung. In the context of the urological analysis in the ASV discussed, patients and patients are treated with care, this is precisely defined. Therefore, the Rule does not include excessive treatment by Haus- or Facharzt. Make sure you have a specific diagnosis.

Erster officer Austausch

Under the motto “Let’s talk about ASV” we published information and information information. Hegemann has investigated the medical department of ASV Urological Tumors and that of very serious consequences for affected patients and patients, also for new drugs. The message of the first time that the lungs move and the experience that the gemeinsam is wrong has arisen. It is a central partner and a leader in ambulatory care, patient involvement and information provision in the care team.

Consider the selection of team leaders and experts in their personal references from the experts of the Gronauer ASV teams. MD Eiad Ibrahim, Oberarzt of the Clinic for Hämatology and Oncology/Palliative Medizin, proposes a new combination therapy for the treatment of metastases from urothelkarzines. Prof. Dr. Kambiz Rahbar, chef of the Klinik for Nuklearmedizin, informs you about the new dates with the PSMA Ligand Therapy.